Company Filing History:
Years Active: 1994
Title: Innovations of Katsumi Kawaharajo
Introduction
Katsumi Kawaharajo is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative approach has led to the development of a unique method for inhibiting tumor growth.
Latest Patents
Kawaharajo holds a patent for a method of inhibiting tumor growth using xanthocillin X dimethylether. This patent outlines that tumor growth in a mammal can be inhibited by administering an effective amount of xanthocillin X dimethylether. The recommended dosage ranges from 10 to 3,000 milligrams per day for an average adult human patient. The xanthocillin X dimethylether can be administered through various methods, including orally, by direct application into a neoplastic lesion, or through parenteral forms such as intravenous, subcutaneous, or intramuscular injections. Additionally, suppository forms can also be utilized.
Career Highlights
Kawaharajo is associated with Meiji Seika Kaisha, Ltd., where he has been able to apply his innovative ideas in a professional setting. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
Kawaharajo has collaborated with notable colleagues, including Tsutomu Tsuruoka and Harumi Fukuyasu. Their combined efforts have contributed to the success of their projects and innovations.
Conclusion
Katsumi Kawaharajo's work in developing methods to inhibit tumor growth showcases his dedication to advancing medical science. His innovative patent reflects the potential for significant improvements in cancer treatment.